Research Topics
Genomes and GenesSpecies | Andrew S LeveySummaryAffiliation: Tufts Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Conceptual model of CKD: applications and implicationsAndrew S Levey
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 53:S4-16. 2009....
Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and PreventionAndrew S Levey
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 53:522-35. 2009..Cooperation among federal, state, and local governmental and private organizations will be necessary to carry out these recommendations...
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference reportAndrew S Levey
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA
Kidney Int 80:17-28. 2011..KDIGO has now convened a workgroup to develop a global clinical practice guideline for the definition, classification, and prognosis of chronic kidney disease...
Chronic kidney disease, diabetes, and hypertension: what's in a name?Andrew S Levey
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 78:19-22. 2010..We provide data on the frequency of diabetes, hypertension, or both, according to albumin-to-creatinine ratio and eGFR, and review the rationale for retaining the current name...
Living donor kidney transplantation in the United States--looking back, looking forwardAndrew S Levey
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 58:343-8. 2011....
Chronic kidney diseaseAndrew S Levey
William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Lancet 379:165-80. 2012..In this Seminar we discuss disease burden, recommendations for assessment and management, and future challenges. We emphasise clinical practice guidelines, clinical trials, and areas of uncertainty...
Waist-to-hip ratio, body mass index, and subsequent kidney disease and deathEssam F Elsayed
Nephrology Research Center, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 52:29-38. 2008..Chronic kidney disease (CKD) and obesity are important public health concerns. We examined the association between anthropomorphic measures and incident CKD and mortality...
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKDEssam F Elsayed
Department of Medicine, Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 52:49-57. 2008..Waist-to-hip ratio (WHR) is less influenced by muscle and bone mass than body mass index (BMI). We compared WHR and BMI as risk factors for cardiac events (myocardial infarction and fatal coronary disease) in persons with CKD...
Factors associated with lipoprotein(a) in chronic kidney diseaseKatrin Uhlig
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 45:28-38. 2005....
Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney diseaseVandana Menon
Department of Medicine, Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 42:44-52. 2003..CRP levels are independently associated with serum albumin level and CVD prevalence. Inflammation may be involved in the pathophysiological state of malnutrition and CVD in the earlier stages of predominantly nondiabetic kidney disease...
A predictive model for progression of chronic kidney disease to kidney failureNavdeep Tangri
Department of Medicine, Tufts Medical Center, 800 Washington St, PO Box 391, Boston, MA 02111, USA
JAMA 305:1553-9. 2011....
Relationship of phosphorus and calcium-phosphorus product with mortality in CKDVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 46:455-63. 2005....
The Framingham predictive instrument in chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 50:217-24. 2007..We sought to determine the utility of the Framingham equations in individuals with chronic kidney disease (CKD)...
Role of adipose tissue in determining muscle mass in patients with chronic kidney diseaseCarmen Castaneda-Sceppa
Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA
J Ren Nutr 17:314-22. 2007..Arm muscle area was used as an indicator of muscle mass...
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKDDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 51:212-23. 2008..Chronic kidney disease is associated with increased risk for cardiovascular disease and mortality. Both traditional and nontraditional cardiovascular disease risk factors may contribute...
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney diseaseMarc A Pfeffer
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 361:2019-32. 2009..Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested...
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 16:3411-7. 2005..43; P = 0.07). HbA(1c) is associated with increased mortality in nondiabetic kidney disease. Hyperglycemia may be a potential therapeutic target and HbA(1c) may be important as a risk stratification tool in this high-risk population...
Erythropoietic response and outcomes in kidney disease and type 2 diabetesScott D Solomon
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02114, USA
N Engl J Med 363:1146-55. 2010..However, target-based strategies are confounded by each patient's individual hematopoietic response...
Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological responseCraig E Gordon
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA
Clin J Am Soc Nephrol 4:1449-58. 2009..The authors aimed to identify factors associated with SVR in hemodialysis patients through analysis of individual patient data obtained from systematic review of published literature...
Cystatin C as a risk factor for outcomes in chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 147:19-27. 2007....
Relationship between homocysteine and mortality in chronic kidney diseaseVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Circulation 113:1572-7. 2006..Prior studies demonstrating an association between tHcy and CVD risk may have inadequately adjusted for the confounding effects of kidney function...
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyVandana Menon
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 53:208-17. 2009..We examined the effect of a very low-protein diet on the development of kidney failure and death during long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study...
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instrumentsDana C Miskulin
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Nephrol Dial Transplant 19:413-20. 2004..We compare the discriminatory accuracy of 1 year mortality predictions derived from four comorbidity instruments in a large representative US dialysis population...
Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyLaura C Plantinga
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Am J Kidney Dis 49:831-40. 2007..Knowing whether risk factors for mortality differ in dialysis patients who survive longer and the strengths of these risk factors for mortality change over time would assist physicians in making better prognostic judgments...
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney diseasePanagiotis T Vlagopoulos
Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 16:3403-10. 2005..66) for all-cause mortality. Anemia was not a risk factor for any outcome in those without CKD (P > 0.2 for all outcomes). In persons with diabetes, anemia is primarily a risk factor for adverse outcomes in those who also have CKD...
Uric acid and long-term outcomes in CKDMagdalena Madero
Department of Medicine, Division of Nephrology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
Am J Kidney Dis 53:796-803. 2009..Hyperuricemia is prevalent in patients with chronic kidney disease (CKD); however, data are limited about the relationship of uric acid levels with long-term outcomes in this patient population...
Serum β-trace protein and risk of mortality in incident hemodialysis patientsTariq Shafi
Division of Nephrology, Johns Hopkins University School of Medicine, 301 Mason Lord Drive, Suite 2500, Baltimore, MD 21224 2780, USA
Clin J Am Soc Nephrol 7:1435-45. 2012..The objective of this study was to determine the association of serum β-trace protein with mortality in incident hemodialysis patients...
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysisTazeen H Jafar
Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 139:244-52. 2003..0 g/d. Systolic blood pressure less than 110 mm Hg may be associated with a higher risk for kidney disease progression...
Cardiovascular disease and subsequent kidney diseaseEssam F Elsayed
Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Campus Box 391, Boston, MA 02111
Arch Intern Med 167:1130-6. 2007..Chronic kidney disease is a risk factor for cardiovascular disease (CVD); however, it is uncertain if CVD is a risk factor for progression or development of kidney disease...
Level of kidney function as a risk factor for cardiovascular outcomes in the elderlyGuruprasad Manjunath
Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
Kidney Int 63:1121-9. 2003..A linear model best described the relationship between GFR and CVD. CONCLUSION: The level of GFR is an independent risk factor for CVD, de novo CVD, and all-cause mortality in the elderly...
Comorbidity and its change predict survival in incident dialysis patientsDana C Miskulin
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 41:149-61. 2003..Longitudinal change in the comorbid illness burden of incident dialysis patients has not been measured. Comorbidity severity and its change may serve as important prognostic markers of survival, independent of other case-mix factors...
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysisTazeen H Jafar
New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
Nephrol Dial Transplant 18:2047-53. 2003..Therefore, we undertook this analysis to explore the independent association of renal disease progression with gender...
Factors other than glomerular filtration rate affect serum cystatin C levelsLesley A Stevens
Division of Nephrology, Clinical Care Research, Tufts Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 75:652-60. 2009..Hence, we found that cystatin C is affected by factors other than GFR which should be considered when the GFR is estimated using serum levels of cystatin C...
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKDLesley A Stevens
Division of Nephrology, Tufts New England Medical Center, 750 Washington St, Box 391, Boston, MA 02111, USA
Am J Kidney Dis 51:395-406. 2008..We report the development and evaluation of GFR-estimating equations using serum cystatin C alone and serum cystatin C, serum creatinine, or both with demographic variables...
Kidney disease as a risk factor for recurrent cardiovascular disease and mortalityDaniel E Weiner
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 44:198-206. 2004..CONCLUSION: The presence of CKD in a community-based population with preexisting CVD is associated with an increased risk for recurrent CVD outcomes. This increased risk persists after adjustment for traditional CVD risk factors...
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitaminsVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 67:1539-46. 2005..There is insufficient evidence to suggest that low tHcy is associated with poor nutritional status in the MDRD Study cohort. B vitamins and GFR, but not dietary protein, are the major determinants of tHcy in this patient population...
Body mass index and mortality in CKDMagdalena Madero
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 50:404-11. 2007..Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD)...
A new equation to estimate glomerular filtration rateAndrew S Levey
Tufts Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 150:604-12. 2009..Equations to estimate glomerular filtration rate (GFR) are routinely used to assess kidney function. Current equations have limited precision and systematically underestimate measured GFR at higher values...
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 68:766-72. 2005..High CRP, but not serum albumin, is a risk factor for cardiovascular mortality. These results suggest that high CRP and hypoalbuminemia provide prognostic information independent of each other in CKD...
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney diseaseTazeen H Jafar
Division of Nephrology, New England Medical Center, Boston, Massachusetts, USA
Kidney Int 67:265-71. 2005..We performed a patient-level meta-analysis to compare the effect of antihypertensive regimens, including ACE inhibitors, to those without ACE inhibitors (controls) on kidney disease progression in patients with PKD...
Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyAndrew S Levey
Division of Nephrology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Am J Kidney Dis 48:879-88. 2006..CONCLUSION: The efficacy of a 2- to 3-year intervention of dietary protein restriction on progression of nondiabetic kidney disease remains inconclusive. Future studies should include a longer duration of intervention and follow-up...
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)Garabed Eknoyan
Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Am J Kidney Dis 42:617-22. 2003
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rateNavdeep Tangri
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 79:471-7. 2011..Hence, cystatin C may allow more accurate estimates of GFR than creatinine for patients with reduced protein intake. Further study of other non-GFR determinants of cystatin C is needed before the widespread adoption...
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient databaseLesley A Stevens
Division of Nephrology, Tufts New England Medical Center, 750 Washington St, Box 391, Boston, MA 02111, USA
Am J Kidney Dis 50:21-35. 2007..Variation in performance of glomerular filtration rate (GFR) estimating equations is related to variation in calibration of the creatinine assay across clinical laboratories...
Estimating glomerular filtration rate from serum creatinine and cystatin CLesley A Inker
Division of Nephrology, Tufts Medical Center, 800 Washington St, Box 391, Boston, MA 02111, USA
N Engl J Med 367:20-9. 2012..Cystatin C is an alternative filtration marker for estimating GFR...
Filtration markers may have prognostic value independent of glomerular filtration rateNavdeep Tangri
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
J Am Soc Nephrol 23:351-9. 2012..trace protein and cystatin C seem to provide more consistent prognostic information than creatinine...
CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort studyDaniel E Weiner
Division of Nephrology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
BMC Nephrol 10:26. 2009..It is unknown whether defining chronic kidney disease (CKD) based on one versus two estimated glomerular filtration rate (eGFR) assessments changes the prognostic importance of reduced eGFR in a community-based population...
Association between body mass index and CKD in apparently healthy menRebecca P Gelber
Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02120, USA
Am J Kidney Dis 46:871-80. 2005..06 to 1.53). CONCLUSION: In this large cohort of initially healthy men, BMI was associated significantly with increased risk for CKD after 14 years. Strategies to decrease CKD risk might include prevention of overweight and obesity...
Prevalence of ICD-9-CM codes for chronic kidney disease in individuals with cardiovascular disease risk factorsAshish Mahajan
Tufts Medical Center Scientific and Clinical Research Center, Boston, Massachusetts, USA
J Nephrol 22:523-33. 2009..Chronic kidney disease (CKD) is a risk factor for cardiovascular disease (CVD)...
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease studyMark J Sarnak
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 142:342-51. 2005..Hypertension is a risk factor for progression of chronic kidney disease. The optimal blood pressure to slow progression is unknown...
Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patientsSharon Stein Merkin
Division of Geriatrics, Department of Medicine, Geffen School of Medicine, University of California Los Angeles, California, USA
J Clin Epidemiol 60:634-42. 2007..To compare self-report of eight diseases with review of medical records and physician reports...
Adiponectin and mortality in patients with chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Division of Nephrology, 750 Washington Street, NEMC 391, Boston, MA 02111, USA
J Am Soc Nephrol 17:2599-606. 2006..Further studies are necessary to confirm this association and to elucidate the underlying mechanisms...
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the communityGuruprasad Manjunath
Division of Nephrology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 41:47-55. 2003..13) for ASCVD, de novo ASCVD, and recurrent ASCVD, respectively. A nonlinear model did not fit the data better than a linear model. CONCLUSIONS: The level of GFR is an independent risk factor for ASCVD and de novo ASCVD in the ARIC study...
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular diseaseDaniel E Weiner
Division of Nephrology, Department of Internal Medicine, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 48:392-401. 2006..Concurrently, CVD may promote CKD, resulting in a vicious cycle. We evaluated this hypothesis by exploring whether CKD and CVD have an additive or synergistic effect on future cardiovascular and mortality outcomes...
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Box 391, Tufts New England Medical Center, Boston, MA 02111, USA
J Am Soc Nephrol 18:960-6. 2007..CKD and elevated SBP are independent risk factors for incident stroke. In CKD, individuals with the lowest BP are at increased risk for stroke. This pattern is not seen in the general population...
Key comorbid conditions that are predictive of survival among hemodialysis patientsDana Miskulin
Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box 391, Boston, MA 02111, USA
Clin J Am Soc Nephrol 4:1818-26. 2009..We sought to determine which conditions are most prognostic and whether comorbidity continues to contribute to a survival model once laboratory and clinical parameters have been accounted for...
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2Lesley A Stevens
Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 56:486-95. 2010..Here, performance of a more accurate GFR-estimating equation, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, is reported by level of GFR and clinical characteristics...
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine valuesAndrew S Levey
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Clin Chem 53:766-72. 2007..We sought to reexpress the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation for estimation of glomerular filtration rate (GFR) using serum creatinine (S(cr)) standardized to reference methods...
Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT)Aron M Troen
Nutrition and Neurocognition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
J Ren Nutr 22:268-76.e1-3. 2012..Accordingly, we assessed the prevalence of cognitive impairment and depressive symptoms in transplant recipients and their association with kidney function, plasma total homocysteine, and B-vitamin concentrations...
Development and validation of GFR-estimating equations using diabetes, transplant and weightLesley A Stevens
Tufts Medical Center, Boston, MA, USA
Nephrol Dial Transplant 25:449-57. 2010..Here, we describe the development and validation of this equation as well as other equations that incorporate diabetes, transplant and weight as additional predictor variables...
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKDAkshay S Desai
Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Kidney Dis 58:717-28. 2011..We examined the value of troponin T (TnT) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in assessing the risk of developing end-stage renal disease (ESRD) in diabetic patients with CKD...
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Marc A Pfeffer
Cardiovascular Division, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Kidney Dis 54:59-69. 2009....
Assessing kidney function--measured and estimated glomerular filtration rateLesley A Stevens
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
N Engl J Med 354:2473-83. 2006
Demographics and trends in overweight and obesity in patients at time of kidney transplantationAllon N Friedman
Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA
Am J Kidney Dis 41:480-7. 2003..The authors describe the prevalence, demographics, and trends in overweight and obesity at the time of kidney transplantation...
Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patientsLaura C Plantinga
Welch Center for Prevention, Epidemiology and Clinical Research, Department of Medicine, Johns Hopkins Medical Institutions, 2024 E. Monument Street, Suite 2-600, Baltimore, MD 21205, USA
J Am Soc Nephrol 15:3144-53. 2004..This association may be due to the positive effect of collaborative discussion by the patient care team of short- and long-term care goals for individual patients...
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney diseaseDavid M Kent
Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, 750 Washington Street 63, Boston, MA 02111, USA
J Am Soc Nephrol 18:1959-65. 2007..Patients with proteinuria <500 mg/d do not seem to benefit, even when at relatively high risk for progression...
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 16:1803-10. 2005..15 [95% CI, 2.62 to 6.56] and 3.92 [95% CI, 2.05 to 7.48]; P = 0.02 and 0.01 for interaction term, respectively). The combination of anemia and LVH in CKD identifies a high-risk population...
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studiesDaniel E Weiner
Division of Nephrology, Department of Clinical Care Research, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 15:1307-15. 2004..It is hypothesized that this effect may be due to more frequent or more severe subclinical vascular disease secondary to hypertension or diabetes in black individuals...
Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease StudyMark J Sarnak
New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Kidney Int 62:2208-15. 2002..In vitro and in vivo data suggest that markers of inflammation and nutritional status may be risk factors for the progression of chronic kidney disease...
Kidney disease, Framingham risk scores, and cardiac and mortality outcomesDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, Mass 02111, USA
Am J Med 120:552.e1-8. 2007..The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance...
Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney diseaseLesley A Stevens
Tufts New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 16:2439-48. 2005....
Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal DiseaseDana C Miskulin
Division of Nephrology, New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 39:324-36. 2002..Adjustment for case-mix differences in patients treated with PD versus HD is essential to the assessment of the independent effect of the dialysis modality on outcomes...
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey
Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 54:205-26. 2009..We recommend collaboration among many groups, including academia, industry, the FDA, and the National Institutes of Health, to share data from past and future studies...
Surrogate end points for clinical trials of kidney disease progressionLesley A Stevens
Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
Clin J Am Soc Nephrol 1:874-84. 2006
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicitiesLesley A Stevens
Division of Nephrology, Tufts Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 79:555-62. 2011..Thus, heterogeneity in performance among the ethnic and geographic groups precludes use of the four-level race equation. The CKD-EPI two-level race equation can be used in the United States and Europe across a wide range of ethnicity...
Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definitionNicholas Stoycheff
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 54:840-9. 2009..These threshold levels have not been rigorously evaluated in patients with diabetic kidney disease or by using urine albumin excretion, the preferred measure of proteinuria in patients with diabetes...
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound eldersDaniel E Weiner
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 53:438-47. 2009..Albuminuria, a kidney marker of microvascular disease, may herald microvascular disease elsewhere, including in the brain...
Traditional cardiac risk factors in individuals with chronic kidney diseaseKatrin Uhlig
Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Semin Dial 16:118-27. 2003..Treatment recommendations are provided using evidence available from populations with CKD or evidence extrapolated from the general population when there are insufficient data on individuals with CKD...
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equationsLesley A Stevens
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 54:33-42. 2009....
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Andrew S Levey
Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 67:2089-100. 2005..Kidney disease treatment by dialysis and transplantation should be noted. Simple, uniform classifications of CKD by cause and by risks for kidney disease progression and CVD should be developed...
Automatic reporting of estimated glomerular filtration rate--just what the doctor orderedAndrew S Levey
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA 02111, USA
Clin Chem 52:2188-93. 2006
Measured GFR as a confirmatory test for estimated GFRLesley A Stevens
Tufts Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 20:2305-13. 2009..We suggest plasma clearance of nonradioactive markers be more widely implemented in clinical settings. Further research is necessary on the impact of the use of measured GFR as a confirmatory test...
Current status and future perspectives for CKD testingLesley A Stevens
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 53:S17-26. 2009..Repeated testing for urine protein and interpretation of GFR estimates in the context of kidney damage and the clinical context of patient presentation can help overcome these limitations...
Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living studyClara Y Jones
Tufts University School of Medicine, Boston, MA 02111, USA
Am J Kidney Dis 51:914-24. 2008..Serum creatinine level may underestimate the prevalence of CKD in subjects with decreased lean body mass or liver disease. Level of serum cystatin C, an alternative kidney function marker, is independent of lean body mass...
Impact of reporting estimated glomerular filtration rate: it's not just about usLesley A Stevens
Tufts Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 76:245-7. 2009..In our view, a complete assessment requires a broader perspective. Most patients with CKD do not require referral to a nephrologist. Improving outcomes requires coordinated efforts of all physicians...
Advances in glomerular filtration rate-estimating equationsLesley A Stevens
Division of Nephrology, Tufts Medical Center, Boston, Massachusetts 02111, USA
Curr Opin Nephrol Hypertens 19:298-307. 2010..Here, we review the performance of current creatinine and cystatin C-based estimating equations as well as demonstration of their utility in public health and clinical practice...
Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled datasetNicholas Stoycheff
Tufts Medical Center, Boston, MA, USA
Nephrol Dial Transplant 26:848-57. 2011..There is a reasonably sound biological basis for this hypothesis, but only preliminary empirical evidence currently exists...
Ethnic subgroup differences in hypertension in PakistanTazeen H Jafar
Department of Community Health Sciences, Tufts University Medical School, Boston, Massachusetts, USA
J Hypertens 21:905-12. 2003..Further study would provide valuable etiological and therapeutic clues...
Evaluation of the modification of diet in renal disease study equation in a large diverse populationLesley A Stevens
Division of Nephrology, Tufts New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 18:2749-57. 2007..73 m(2). In individual patients, interpretation of GFR estimates near 60 ml/min per 1.73 m(2) should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting...
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAndrew S Levey
Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
Ann Intern Med 139:137-47. 2003..Because of the high prevalence of early stages of chronic kidney disease in the general population (approximately 11% of adults), this information is particularly important for general internists and specialists...
Should the K/DOQI definition of chronic kidney disease be changed?Andrew S Levey
Division of Nephrology, Tufts University School of Medicine, Tufts New England Medical Center, Boston, MA, USA
Am J Kidney Dis 42:626-30. 2003
